Towards a Four-Component GMMA-Based Vaccine against

GMMA OMV Shigella outer membrane vesicles vaccine

Journal

Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355

Informations de publication

Date de publication:
18 Feb 2022
Historique:
received: 12 01 2022
revised: 05 02 2022
accepted: 16 02 2022
entrez: 26 2 2022
pubmed: 27 2 2022
medline: 27 2 2022
Statut: epublish

Résumé

Shigellosis remains a major public health problem around the world; it is one of the leading causes of diarrhoeal disease in low- and middle-income countries, particularly in young children. The increasing reports of

Identifiants

pubmed: 35214786
pii: vaccines10020328
doi: 10.3390/vaccines10020328
pmc: PMC8880054
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

Front Immunol. 2021 May 04;12:671325
pubmed: 34017343
Vaccine. 1990 Aug;8(4):353-7
pubmed: 2204243
J Biol Chem. 2014 Sep 5;289(36):24922-35
pubmed: 25023285
J Biol Chem. 2020 Jul 31;295(31):10593-10609
pubmed: 32424042
Bull World Health Organ. 1968;39(3):375-80
pubmed: 5303905
Dev Biol Stand. 1998;92:323-33
pubmed: 9554288
Semin Immunol. 2020 Aug;50:101433
pubmed: 33309166
J Infect Dis. 1997 May;175(5):1128-33
pubmed: 9129076
PLoS Pathog. 2015 Mar 20;11(3):e1004749
pubmed: 25794007
J Clin Microbiol. 1991 Feb;29(2):386-9
pubmed: 1706731
J Infect Public Health. 2018 Jul - Aug;11(4):451-454
pubmed: 29066021
Vaccines (Basel). 2020 Sep 17;8(3):
pubmed: 32957610
ACS Omega. 2017 Nov 30;2(11):8282-8289
pubmed: 30023580
Bull World Health Organ. 1965;32(5):647-55
pubmed: 5294180
Proc Natl Acad Sci U S A. 2018 Oct 9;115(41):10428-10433
pubmed: 30262653
Expert Rev Anti Infect Ther. 2015 Jan;13(1):69-80
pubmed: 25399653
Vaccine. 2017 Jan 11;35(3):419-426
pubmed: 27998639
PLoS One. 2012;7(6):e35616
pubmed: 22701551
Mol Cell Proteomics. 2008 Mar;7(3):473-85
pubmed: 17982123
Proteomics. 2006 Mar;6(6):1856-66
pubmed: 16456881
J Bacteriol. 1998 Sep;180(18):4872-8
pubmed: 9733690
Int J Med Microbiol. 2016 Feb;306(2):99-108
pubmed: 26746581
Clin Infect Dis. 2014 Oct;59(7):933-41
pubmed: 24958238
Vaccine. 2016 Jun 3;34(26):2887-2894
pubmed: 26979135
Sci Rep. 2021 Jan 13;11(1):906
pubmed: 33441861
PLoS One. 2015 Aug 06;10(8):e0134478
pubmed: 26248044
J Biotechnol. 2015 Mar 20;198:46-52
pubmed: 25659926
Lancet Infect Dis. 2021 Apr;21(4):546-558
pubmed: 33186516
Microorganisms. 2021 Jun 25;9(7):
pubmed: 34202102
Microorganisms. 2021 Nov 15;9(11):
pubmed: 34835485
EBioMedicine. 2017 Aug;22:164-172
pubmed: 28735965
Vaccines (Basel). 2020 Apr 03;8(2):
pubmed: 32260067
Vaccine. 2014 May 13;32(23):2688-95
pubmed: 24704334
Bull World Health Organ. 1971;45(4):457-64
pubmed: 4948417
Lancet. 2016 Sep 24;388(10051):1291-301
pubmed: 27673470
EClinicalMedicine. 2021 Aug 13;39:101076
pubmed: 34430837
J Infect Dis. 1991 Sep;164(3):533-7
pubmed: 1869840
Int J Mol Sci. 2021 Sep 22;22(19):
pubmed: 34638530
Clin Vaccine Immunol. 2016 Dec 5;23(12):908-917
pubmed: 27581434
Int J Mol Sci. 2021 Jan 28;22(3):
pubmed: 33525644
Int J Mol Sci. 2020 Jun 21;21(12):
pubmed: 32575921
Methods Mol Biol. 2022;2414:227-279
pubmed: 34784041
Front Immunol. 2021 Aug 03;12:715393
pubmed: 34413858
Vaccine. 2010 Mar 2;28(10):2231-2235
pubmed: 20056180
EBioMedicine. 2021 Apr;66:103310
pubmed: 33862589
Vaccine. 1995 Nov;13(16):1488-94
pubmed: 8578831
Lancet Glob Health. 2019 May;7(5):e568-e584
pubmed: 31000128
mBio. 2018 Mar 6;9(2):
pubmed: 29511082
Front Immunol. 2017 Dec 22;8:1884
pubmed: 29375556
Am J Epidemiol. 1991 Sep 15;134(6):614-27
pubmed: 1951266
Lancet. 1997 Jan 18;349(9046):155-9
pubmed: 9111538
Appl Environ Microbiol. 2019 Mar 22;85(7):
pubmed: 30709819
Lancet Glob Health. 2020 Feb;8(2):e215-e224
pubmed: 31981554
Vaccines (Basel). 2021 Mar 06;9(3):
pubmed: 33800727
PLoS One. 2016 Aug 04;11(8):e0157385
pubmed: 27490698
Clin Vaccine Immunol. 2016 Apr 04;23(4):304-14
pubmed: 26865597
Infect Immun. 2004 Apr;72(4):1914-9
pubmed: 15039310
Infect Immun. 2001 Jul;69(7):4545-53
pubmed: 11401998
J Infect Dis. 2020 Nov 9;222(11):1858-1868
pubmed: 31984416
Biotechnol J. 2019 Jan;14(1):e1800376
pubmed: 30537361
Nat Rev Immunol. 2010 Nov;10(11):787-96
pubmed: 20948547
Hum Vaccin Immunother. 2020;16(1):197-205
pubmed: 31287754
Front Immunol. 2019 Mar 08;10:335
pubmed: 30906291
J Infect Dis. 1972 Jan;125(1):12-6
pubmed: 4550416
J Clin Microbiol. 1989 Jan;27(1):162-7
pubmed: 2463995
Lancet Infect Dis. 2018 Nov;18(11):1229-1240
pubmed: 30266330
J Infect Dis. 1988 May;157(5):1068-71
pubmed: 3283258
Acta Microbiol Acad Sci Hung. 1974;21(1-2):109-14
pubmed: 4613128
J Extracell Vesicles. 2013 May 06;2:
pubmed: 24009891
PLoS Negl Trop Dis. 2021 Oct 13;15(10):e0009826
pubmed: 34644291
Hum Vaccin Immunother. 2019;15(6):1401-1408
pubmed: 31070988

Auteurs

Francesca Micoli (F)

GSK Vaccines Institute for Global Health (GVGH) S.r.l., 53100 Siena, Italy.

Usman N Nakakana (UN)

GSK Vaccines Institute for Global Health (GVGH) S.r.l., 53100 Siena, Italy.

Francesco Berlanda Scorza (F)

GSK Vaccines Institute for Global Health (GVGH) S.r.l., 53100 Siena, Italy.

Classifications MeSH